Lexaria Bioscience Corp. (NASDAQ: LEXX) (CSE: LXX) Is ‘One to Watch’
Lexaria Bioscience Corp. has disruptive proprietary technology protected by a broad international patent portfolioThe company has been issued 19 patents in the U.S., European Union and other countries, with more than 50 patents pending around the worldLexaria’s DehydraTECH technology has a vast worldwide, multi-billion-dollar total addressable market, including multiple rapid-growth segments like cannabinoid and noncombustible nicotine deliveryThe company has licensed its fat-soluble active molecule delivery…